Suprapubic percutaneous sclero-embolization of symptomatic female pelvic varicocele under local anesthesia

Andrea Tinelli, A Tinelli, R Prudenzano, M Torsello, Massimo Torsello, A Malvasi, Antonio Malvası, Giorgio De Nunzio, G De Nunzio, I. De Mitri, Mario A. Bochicchio, M Bochicchio, Daniel A. Tsin, D A Tsin, P Krishnan, Prakash Krishnan, J M Wiley, Jose Wiley
European review for medical and pharmacological sciences · 2012 · vol. 16(1) , pp. 111–7 · PMID:22338556 · W2181967082
Other OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-24 ⓘ

Suprapubic percutaneous sclero-embolization of symptomatic female pelvic varicocele under local anesthesia demonstrated 100% technical success with minimal complications and significant symptom reduction.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

PURPOSE: To evaluate the safety and feasibility of supra-pubic percutaneous sclero-embolization (SE) in the treatment of symptomatic female pelvic varicocele (FPV), performed under local anesthesia. MATERIALS AND METHODS: The authors selected 28 patients screened by transabdominal and transvaginal ultrasound, with venous Doppler signal. Clinicians performed SE by transfemoral catheterization, under local anesthesia, using of a mix of 2 ml of lauromacrogol 400 (Atossisclerol 3%, Chemische F. Kreussler, Wiesbaden, Germany) and 2 ml of air, in a mixed foam fashion. RESULTS: The total operative time for SE was 7.6 +/- 2.1 min. Intra-surgical blood loss was 40 +/- 14 ml. No migration of sclerosant material occurred and postoperative analgesic request during a 48 hr period occurred in 6 patients. Technical success was 100%. The Authors embolized 8 women bilaterally (28.5%), 18 on the left ovarian vein (OV) (64.2%) and 2 only in the right OV (7.1%): 7 women complained of transitory flank pain (25%), which disappeared in few minutes. The major complications in 10 days after SE were: fever (> 38 degrees C for two days) in 2 patients (7.1%) and pelvic pain for 3 days in eight patients (28.5%). After 30 days only 6 women suffered of FPV lower symptoms which disappeared in 180 days. A substantial reduction in size of pelvic varicosities was noted in all patients. CONCLUSIONS: SE is a safe and feasible procedure. It reduces significantly the mean time of scopies, the intensity of radiation emission, and it is performed under local anaesthesia. This minimally invasive procedure could be proposed to all women with supra-pubic FPV for its reproducibility and feasibility.

My notes (saved in your browser only)

MeSH descriptors

Anesthesia, Local Embolization, Therapeutic Pelvis Pelvis Varicocele Adult Female Fluoroscopy Humans Male Middle Aged Pain Measurement Postoperative Pain Postoperative Pain Regional Blood Flow Sclerosing Solutions Sclerosing Solutions Sexual Behavior Surgery, Computer-Assisted Treatment Outcome

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (23)

Source provenance

openalex
last seen: 2026-05-14T06:54:16.401154+00:00
pubmed
last seen: 2026-10-08T21:10:02.438825+00:00
License: CC0 · commercial use OK